Home
About
Overview
Sharing Data
ORCID
Help
History (20)
Prevalence of Early Knee Osteoarthritis Illness Among Various Patient-Reported Classification Criteria After Anterior Cruciate Ligament Reconstruction.
Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator.
gag Gene Products, Human Immunodeficiency Virus
CCCTC-Binding Factor
The heart of the matter: reducing CVD risk.
See All 20 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The heart of the matter: reducing CVD risk.
Hayman LL, Kamau MW, Stuart-Shor EM. The heart of the matter: reducing CVD risk. Nurse Pract. 2009 May; 34(5):30-5.
View in:
PubMed
subject areas
Cardiovascular Diseases
Evidence-Based Practice
Global Health
Humans
Life Style
Nurse Practitioners
Practice Guidelines as Topic
Primary Health Care
Primary Prevention
Risk Reduction Behavior
Secondary Prevention
United States
authors with profiles
Laura L Hayman PhD